JPMA Responds to the 2025 Honebuto Policy: Emphasizing Reform of Cost-Effectiveness Evaluation and Pricing Framework
Introduction to Japan’s 2025 Honebuto Policy According to a news article (製薬協 費用対効果評価「現行の枠組みにとらわれない新たな制度のあり方含め検討を」 骨太方針2025受け | ニュース | ミクスOnline) published by MIX Online on June 13, 2025, the Japanese government approved the “Basic Policy on Economic and Fiscal Management and Reform 2025” (Honebuto Policy), which outlines key healthcare priorities, including the reinforcement of cost-effectiveness evaluation (CEE) and potential […]